Main menu

Diagnosing the undiagnosed with long-read genome data


In this talk, Wendy Chung shares how her team at Boston Children's Hospital are using Oxford Nanopore sequencing to help uncover answers in unsolved, short-read negative rare disease cases.

See our blog article for more on how Dr Chung and others are demonstrating the potential of nanopore sequencing to reshape rare disease diagnosis in the future.

Wendy Chung, M.D., Ph.D., is a clinical and molecular geneticist and the Chief of the Department of Pediatrics at Boston Children’s Hospital and the Mary Ellen Avery Professor of Pediatrics at Harvard Medical School.

Please note: This is independent, investigator-led research using Oxford Nanopore technology. Oxford Nanopore products are for research use only, and not for use in diagnostic procedures.

Authors: Wendy Chung, Chief of the Department of Pediatrics at Boston Children's Hospital

入门指南

购买 MinION 启动包 Nanopore 商城 测序服务提供商 全球代理商

纳米孔技术

订阅 Nanopore 更新 资源库及发表刊物 什么是 Nanopore 社区

关于 Oxford Nanopore

新闻 公司历程 可持续发展 领导团队 媒体资源和联系方式 投资者 合作者 在 Oxford Nanopore 工作 职位空缺 商业信息 BSI 27001 accreditationBSI 90001 accreditationBSI mark of trust
Chinese flag